Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - New Orleans, Louisiana

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity’s research site in New Orleans was founded in 2012 as MedPharmics, and acquired by Velocity in 2022. Since its inception, the site has built a reputation of success conducting trials in Infectious Diseases and Women’s Health, and has completed 50+ vaccine trials. Additionally, our New Orleans team is actively expanding to new therapeutic areas to better serve the diverse population of the greater New Orleans area. Velocity Clinical Research New Orleans is conveniently located off of S. Norman C Francis Parkway, just down the street from the University Medical Center on Tulane Ave. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The New Orleans team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Source: Trial-derived.
9Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
6Completed Trials
Source: Trial-derived.
11Unique Conditions
Source: Trial-derived.
7Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Influenza (2)Source: Trial-derived. Gout (1)Source: Trial-derived. Healthy Volunteers (1)Source: Trial-derived. Human (1)Source: Trial-derived. Lower Respiratory Tract Disease (1)Source: Trial-derived. Respiratory Syncytial Viruses (1)Source: Trial-derived. RESPIRATORY SYNCYTIAL VIRUS (RSV) (1)Source: Trial-derived. RSV Immunization (1)

Sponsors

Source: Trial-derived. Sanofi Pasteur, a Sanofi Company (3)Source: Trial-derived. Amgen (1)Source: Trial-derived. Janssen Vaccines & Prevention B.V. (1)Source: Trial-derived. ModernaTX, Inc. (1)Source: Trial-derived. Pfizer (1)Source: Trial-derived. Sanofi (1)Source: Trial-derived. Seqirus (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PBMC isolation & cryopreservation

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. ELISpot assay
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Virus neutralisation assay